TNB-512
Autoimmune Disorders
Phase 1Active
Key Facts
About Tenacia Biotechnology
Clinical-stage biotech developing small molecule therapies for oncology and immunology using proprietary drug discovery platforms.
View full company profileTherapeutic Areas
Other Autoimmune Disorders Drugs
| Drug | Company | Phase |
|---|---|---|
| Biosimilar Candidate | MSN Laboratories | Pre‑clinical |
| TYK2 Pseudokinase Inhibitor | A2A Pharma | Preclinical |
| Marine Membrane Lipid Extract(s) | Arctic Bioscience | Pre-clinical |
| Validated immunology target program | Genesis Therapeutics | Discovery |
| NAMPT - Autoimmune | Remedy Plan Therapeutics | Discovery |
| LZB-201 | Lazuline Biotech | Preclinical |
| Autoimmunity Diagnostics | Eurobio | Commercial |